General Western Blot Reagents
Abcam Malate Dehydrogenase 2 (MDH2) Activity Assay
Malate Dehydrogenase 2 (MDH2) Activity Assay
The product is subject to the following: Abcam Restricted Use Statement
Abcam MRS 2179, P2Y1 antagonist, 50MG
MW 460.27 Da, Purity >98%. Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam Anti-RNF20 antibody [RM1054] - BSA and Azide free.](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502698906.JPG-250.jpg)
Abcam Anti-RNF20 antibody [RM1054] - BSA and Azide free.
Anti-RNF20 antibody [RM1054] - BSA and Azide free.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bufalin, Na+/K+-ATPase inhibitor, 50MG
MW 386.5 Da, Purity >98%. Na+/K+-ATPase inhibitor. Potent steroid receptor coactivators SRC-3 and SRC-1 inhibitor. Induces cell differentiation and apoptosis. Activates AP-1 via JNK. Shows antitumor effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nitrendipine, L-type Ca2+ channel blocker, 500MG
MW 360.4 Da, Purity >98%. L-type Ca2+ channel blocker. Antihypertensive *in vivo*. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 334867, O x 1 receptor antagonist, 50MG
MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin B, H+-ATPase inhibitor, 25UG
MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
The product is subject to the following: Abcam Restricted Use Statement
Abcam C x 546, AMPA receptor potentiator, 50MG
MW 247.29 Da, Purity >99%. AMPA receptor potentiator. Selectively binds to the agonist bound non-desensitized receptor. Destabilizes desensitized receptor conformation with greater potency than CX516. Enhances cognitive function in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Enzyme Mix (lyophilized).
Enzyme Mix (lyophilized).
The product is subject to the following: Abcam Restricted Use Statement
Abcam ICI 182,780, Estrogen receptor antagonist, 10MG
MW 606.8 Da, Purity >99%. Estrogen receptor antagonist with no partial agonist activity. Anticancer agent (IC₅₀ = 0.29 nM for inhibition of breast cancer cell growth). Causes downregulation and loss of estrogen receptors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 8-Azaguanine, purine analogue with antineoplastic activity, 50MG
MW 152.11 g/mol, Purity >99%. Purine analogue with potential antineoplastic activity. Antimetabolite. Competes with guanine. Incorporated into ribonucleic acids, interfering with normal biosynthetic pathways, thus inhibiting cellular growth. Has been used in the treatment of acute leukemia.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BNT x maleate, delta1 opioid receptor antagonist, 50MG
MW 545.6 Da, Purity >97%. Selective δ1 opioid receptor antagonist. Inhibits neurogenic ion transport in porcine ileal mucosa. Increases the antinociceptive ED50 value of DPDPE (ab120675) *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mupirocin, antibiotic agent, 20MG
Mupirocin, antibiotic agent (ab146183) is part of the reagents, controls & accessories range. Abcam offers high-quality biological reagents and tools including antibodies, proteins, assays, cell lines and lysates.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Optovin, photoactive TRPA1 activator, 25MG
MW 315.4 Da. Reversible photoactive TRPA1 activator. Induces light-activated nociceptive motor behavior responses (EC₅₀ = 2 μM) in vivo. .
The product is subject to the following: Abcam Restricted Use Statement